Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SOS1 INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/022497
Kind Code:
A1
Abstract:
Provided are a novel compound of chemical formula I and a use thereof for preventing or treating SOS1-related diseases. A novel compound according to an aspect of the present invention inhibits interaction between SOS1 and a RAS family protein or between SOS1 and RAC1 and thus is useful for preventing or treating SOS1-mediated diseases such as cancer and RASopathy.

Inventors:
YU HA NA (KR)
SHIN YOUNG SOOK (KR)
PARK DOHYUN (KR)
YOON KYEONG JIN (KR)
LIM SANG KYUN (KR)
KIM DONGGEON (KR)
KI DONG HYUK (KR)
KIM EUN-JUNG (KR)
NAM JOONWOO (KR)
HAN WOOSEOK (KR)
YU JIHYUN (KR)
KIM JI EUN (KR)
Application Number:
PCT/KR2022/012254
Publication Date:
February 23, 2023
Filing Date:
August 17, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KANAPH THERAPEUTICS INC (KR)
CYRUS THERAPEUTICS INC (KR)
International Classes:
C07D237/14; A61K31/50; A61P35/00; C07D401/04; C07D405/04; C07D409/04
Domestic Patent References:
WO2014031928A22014-02-27
WO2019122129A12019-06-27
WO2021127429A12021-06-24
WO2008011557A22008-01-24
Foreign References:
KR20150013563A2015-02-05
Other References:
J. MED. CHEM., vol. 64, no. 10, 2021, pages 6569 - 6580
CURRENT OPINION IN CHEMICAL BIOLOGY, vol. 62, 2021, pages 109 - 118
Attorney, Agent or Firm:
RYU, Jong Woo et al. (KR)
Download PDF: